Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Panminerva Medica|May 9, 1998
Nitric oxide plasma levels in patients with chronic and acute cerebrovascular disordersS Ferlito, M Gallina, G M Pitari, et al.Current Molecular Pharmacology|December 22, 2009
Can colorectal cancer be prevented or treated by oral hormone replacement therapy?P Li, J E Lin, S Schulz, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2001
Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cellsG M Pitari, M D Di Guglielmo, J Park, et al.Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|October 20, 2000
Comparison of pharmacological treatment versus acupuncture treatment for migraine without aura--analysis of socio-medical parametersA Liguori, F Petti, A Bangrazi, et al.Drug News & Perspectives|September 23, 2009
GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?P Li, J E Lin, G P Marszlowicz, et al.Clinical Pharmacology and Therapeutics|August 10, 2007
The paracrine hormone hypothesis of colorectal cancerG M Pitari, P Li, J E Lin, et al.Pharmacological Reviews|September 8, 2000
Guanylyl cyclases and signaling by cyclic GMPK A Lucas, G M Pitari, S Kazerounian, et al.Clinical and Translational Science|September 4, 2009
Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapyP Li, J E Lin, A E Snook, et al.Proceedings of the National Academy of Sciences of the United States of America|December 20, 2003
Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolismI Ruiz-Stewart, S R Tiyyagura, J E Lin, et al.Proceedings of the National Academy of Sciences of the United States of America|February 21, 2003
Bacterial enterotoxins are associated with resistance to colon cancerG M Pitari, L V Zingman, D M Hodgson, et al.Pageof 1